Xconomy: Raleigh-Durham top stories News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More	Ben Fidler	09/13/19	National
After First Look at House Drug Plan, Stocks Rise Slightly	Alex Lash	09/10/19	National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards	Ben Fidler	09/10/19	National
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More	Ben Fidler	09/09/19	National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone	Frank Vinluan	09/06/19	National
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More	Alex Lash	08/30/19	National
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)	Alex Lash	08/26/19	National
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug	Frank Vinluan	08/23/19	National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More	Frank Vinluan	08/23/19	National
Ford’s Autonomic Connects EV Maker Ayro to Its Mobility Cloud	Bernadette Tansey	08/21/19	San Francisco
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs	Frank Vinluan	08/16/19	New York
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More	Alex Lash	08/16/19	National
Will Porsche Fans Ever Live in a Driverless World? Porsche Says No.	Bernadette Tansey	08/16/19	San Francisco
Four New Drugs Are Around the Corner. Here’s What You Need to Know.	Ben Fidler	08/15/19	National
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step	Ben Fidler	08/09/19	National
Inari Reaps $89M and Eyes Global Farm Markets for Gene-Edited Seeds	Frank Vinluan	08/06/19	Boston
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More	Frank Vinluan	08/02/19	National
White House Floats Canadian Import Plan But Excludes Many Costly Drugs	Frank Vinluan	07/31/19	National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston	Angela Shah	07/31/19	National
Duchenne Advocates Start Casimir, Aiming to Capture Missing Data	Ben Fidler	07/26/19	Boston
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More	Ben Fidler	07/26/19	National
No Co-Founder? Y Combinator Offers Matchmaking at Startup School	Bernadette Tansey	07/26/19	San Francisco
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown	Frank Vinluan	07/25/19	National
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck	Ben Fidler	07/24/19	New York
Freenome Snags $160M to Boost Blood Test for Early Cancer Detection	Bernadette Tansey	07/24/19	San Francisco
With Regulator’s Nod, Bosch Plans Spread of Driverless Valet Parking	Bernadette Tansey	07/23/19	San Francisco
Could Facebook’s Crypto Break Financial System? Congress Airs Fears	Bernadette Tansey	07/19/19	San Francisco
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More	Frank Vinluan	07/19/19	National
Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts	Frank Vinluan	07/18/19	National
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More	Alex Lash	07/12/19	National
Page 1 of 28	next page »